COVID-19�a Ba�l� Diff�z Alveoler Hemoraji: Olgu Sunumu

Dar�lmaz Y�ce, G�lbahar; Esenda�l�, Dorina; Hekimo�lu, Koray; Tepeo�lu, Merih; Ak�ay, M��erref �ule

Cilt : 13 Say� : 3 Y�l : 2024

13/3Son Say� Erken Bask� Ar�iv Pop�ler Makaleler

Yay�n Hakk� Devir Formu

Yazar Katk� Formu

H�zl� Arama

COVID-19�a Ba�l� Diff�z Alveoler Hemoraji: Olgu Sunumu [Respir Case Rep]

Respir Case Rep. 2022; 11(3): 156-159 | DOI: 10.5505/respircase.2022.66587

COVID-19�a Ba�l� Diff�z Alveoler Hemoraji: Olgu Sunumu

G�lbahar Dar�lmaz Y�ce¹, Dorina Esenda�l�¹, Koray Hekimo�lu², Merih Tepeo�lu³, M��erref �ule Ak�ay¹
¹Ba�kent �niversitesi G��s Hastal�klar� Anabilim Dal�, Ankara
²Ba�kent �niversitesi, Radyoloji Anabilim Dal�, Ankara
³Ba�kent �niversitesi, T�bbi Patoloji Anabilim Dal�, Ankara

Diff�z alveoler hemoraji, �ks�r�k, hemoptizi, yayg�n pulmoner infiltratlar, anemi ve hipoksemik solunum s�k�nt�s� ile karakterize bir sendromdur. Etyolojisinde akci�er enfeksiyonlar� da rol oynamaktad�r. Enfeksiyon riski nedeniyle COVID-19 hastalar�nda bronkoskopi kullan�m�n�n k�s�tlanmas�, diff�z alveoler hemorajinin COVID-19�da yeterince tan�namamas�na neden olmaktad�r. Burada SARS-CoV-2 ba�lam�nda laboratuvar, radyolojik ve bronkoskopik olarak diff�z alveoler hemoraji kan�t� olan 35 ya��ndaki hastada SARS-CoV-2 i�in nasofarengeal s�r�nt� polymerase chain reaction (PCR) testi negatif saptanm��, COVID-19 tan�s� bron� lavaj� ile konulabilmi�tir. Y�ksek enfeksiyon riski nedeniyle pandemi d�neminde bronkoskopi kullan�m�n�n k�s�tlanmas�, SARS-CoV-2 PCR testi negatif imm�nsupresif hastalarda COVID-19 tan�s�n�n yanl��l�kla d��lanmas�na veya SARS-CoV-2 PCR pozitif hastalarda diff�z alveoler hemoraji ve sekonder enfeksiyon gibi durumlar�n yeterince tan�namamas�na neden olmaktad�r.

Anahtar Kelimeler: COVID-19, Diff�z alveolar hemoraji, buzlu cam opasiteler

COVID-19-Associated Diffuse Alveolar Hemorrhage: A Case Report

G�lbahar Dar�lmaz Y�ce¹, Dorina Esenda�l�¹, Koray Hekimo�lu², Merih Tepeo�lu³, M��erref �ule Ak�ay¹
¹Department of Chest Diseases, Ba�kent University, Ankara, T�rkiye
²Department of Radiology, Ba�kent University, Ankara, T�rkiye
³Department of Medical Pathology, Baskent University, Ankara, T�rkiye

Diffuse alveolar hemorrhage is a syndrome characterized by cough, hemoptysis, diffuse pulmonary infiltrates, anemia, and hypoxemic respiratory distress, and lung infections also play a role in its etiology. The restricted use of bronchoscopy in COVID-19 patients due to the risk of infection has led to the poor recognition of diffuse alveolar hemorrhage in COVID-19. We present here the case of a 35-year-old patient with laboratory, radiological and bronchoscopic evidence of diffuse alveolar hemorrhage who was diagnosed with COVID-19 by bronchial lavage. The restrictions on the use of bronchoscopy during the pandemic due to the high risk of infection has led diagnoses of COVID-19 to be mistakenly excluded in immunosuppressive patients with a negative SARS-CoV-2 polymerase chain reaction test, and the under-recognition of conditions such as diffuse alveolar hemorrhage and secondary infection in patients with a positive SARS-CoV-2 PCR.

Keywords: COVID-19, Diffuse alveolar hemorrhage, ground-glass opacities

Olgunun G�r�nt� Kesitleri

Sorumlu Yazar: G�lbahar Dar�lmaz Y�ce, T�rkiye
Makale Dili: �ngilizce

ATIF KOPYALA

Tam Metin PDF At�f dosyas� indir RIS EndNote BibTex Medlars Procite Reference Manager Yazara e-posta g�nder Benzer makaleler PubMed Google Scholar